These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 25133793)

  • 1. Regenerative medicine for the heart: perspectives on stem-cell therapy.
    Cho GS; Fernandez L; Kwon C
    Antioxid Redox Signal; 2014 Nov; 21(14):2018-31. PubMed ID: 25133793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing cell pluripotency for cardiovascular regenerative medicine.
    Chen H; Zhang A; Wu JC
    Nat Biomed Eng; 2018 Jun; 2(6):392-398. PubMed ID: 31011193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac stem cells: biology and clinical applications.
    Goichberg P; Chang J; Liao R; Leri A
    Antioxid Redox Signal; 2014 Nov; 21(14):2002-17. PubMed ID: 24597850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-viral reprogramming and induced pluripotent stem cells for cardiovascular therapy.
    Panda A; Gurusamy N; Rajasingh S; Carter HK; Thomas EL; Rajasingh J
    Differentiation; 2020; 112():58-66. PubMed ID: 31954271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regenerative Neurology and Regenerative Cardiology: Shared Hurdles and Achievements.
    Mitrečić D; Hribljan V; Jagečić D; Isaković J; Lamberto F; Horánszky A; Zana M; Foldes G; Zavan B; Pivoriūnas A; Martinez S; Mazzini L; Radenovic L; Milasin J; Chachques JC; Buzanska L; Song MS; Dinnyés A
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
    Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
    Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induced pluripotent stem cells for cardiac repair.
    Zwi-Dantsis L; Gepstein L
    Cell Mol Life Sci; 2012 Oct; 69(19):3285-99. PubMed ID: 22960788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells.
    Sugiura T; Shahannaz DC; Ferrell BE
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The march of pluripotent stem cells in cardiovascular regenerative medicine.
    Abou-Saleh H; Zouein FA; El-Yazbi A; Sanoudou D; Raynaud C; Rao C; Pintus G; Dehaini H; Eid AH
    Stem Cell Res Ther; 2018 Jul; 9(1):201. PubMed ID: 30053890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem Cells and Their Cardiac Derivatives for Cardiac Tissue Engineering and Regenerative Medicine.
    Roshanbinfar K; Esser TU; Engel FB
    Antioxid Redox Signal; 2021 Jul; 35(3):143-162. PubMed ID: 32993354
    [No Abstract]   [Full Text] [Related]  

  • 11. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
    Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
    Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
    Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for heart regeneration: approaches ranging from induced pluripotent stem cells to direct cardiac reprogramming.
    Yamakawa H; Ieda M
    Int Heart J; 2015; 56(1):1-5. PubMed ID: 25742939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.
    Hodonsky C; Wu K; Mundada L; Si MS
    Curr Pharm Des; 2014; 20(12):2012-22. PubMed ID: 23844731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward the latest advancements in cardiac regeneration using induced pluripotent stem cells (iPSCs) technology: approaches and challenges.
    Farboud SP; Fathi E; Valipour B; Farahzadi R
    J Transl Med; 2024 Aug; 22(1):783. PubMed ID: 39175068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pluripotent Stem Cell-Derived Cardiomyocytes as a Platform for Cell Therapy Applications: Progress and Hurdles for Clinical Translation.
    Oikonomopoulos A; Kitani T; Wu JC
    Mol Ther; 2018 Jul; 26(7):1624-1634. PubMed ID: 29699941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
    Budniatzky I; Gepstein L
    Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maturation status of sarcomere structure and function in human iPSC-derived cardiac myocytes.
    Bedada FB; Wheelwright M; Metzger JM
    Biochim Biophys Acta; 2016 Jul; 1863(7 Pt B):1829-38. PubMed ID: 26578113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem cell therapy for cardiac regeneration: hits and misses.
    Padda J; Sequiera GL; Sareen N; Dhingra S
    Can J Physiol Pharmacol; 2015 Oct; 93(10):835-41. PubMed ID: 26443930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.